Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Wyeth Ltd share price today (on 1 October 2023).
We Provide Best stock tips for Wyeth Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Wyeth Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Wyeth Ltd
Live Chart - Wyeth Ltd
BSE: 500095 | NSE: WYETH | ISIN: INE378A01012Market Cap: [Rs.Cr.] 2,157 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational
Wyeth Ltd, a subsidiary of Wyeth, USA is a global leader in pharmaceuticals, consumer healthcare and animal health products. The company is a market leader in oral contraceptives, hormone Therapy, folic acid and depilatory cream. The Company operates in two segments: pharmaceuticals and others. The pharmaceuticals segment comprises formulations. Formulations comprise oral contraceptives, hormone replacement therapy, antibiotics, vaccines, steroids and other prescription medicines. The others segment comprises over-the-counter pharmaceuticals, cosmetics and other allied consumer products. The company has state-of-the-art manufacturing facility in Goa. Wyeth pioneered the introduction of several new therapies in India. The company was the first to launch hormone therapy.
In the field of vaccines, the company introduced vaccines against HIB and invasive pneumococcal disease in the country. Enbrel, a breakthrough treatment for rheumatoid arthritis and Rapamune, an immuno suppressant for prevention of rejection after renal transplant, Prevenar, a pneumococcal conjugate vaccine and Tygacil, the world's first glycilcycline antibiotic, are among internationally known products launched by Wyeth Ltd in India. Wyeth Ltd was incorporated on September 20, 1947 as a private limited company under the name Lederle Laboratories (India) Ltd. Subsequently, the name was changed to Cynamid India Ltd after their conversion into a public limited company on November 1, 1965.
Subsequently, as part of restructuring, the agro-chemical business of Cynamid India Ltd was transferred to Cynamid Agro Ltd. In April 1997, Cynamid India Ltd merged with the Wyeth Group of companies, Wyeth Laboratories Ltd, John Wyeth (I) Ltd and Wyeth India (P) Ltd. Subsequently, the name of the company was changed to Wyeth Lederle Ltd. On April 1, 2003, pursuant to a Scheme of Amalgamation, the assets, liabilities and reserves of Geoffrey Manners & Co Ltd were transferred to the company with effect from April 1, 2003 and the name of the company was changed to Wyeth Ltd. The company set a state-of-the-art solid dosage facility plant at Verna, Goa at a total cost of Rs 54 crore. The plant commenced their commercial production in June 2002. During the year 2002-03, the company launched RAPAMUNE, an immunosuppressant, for the prevention of organ rejection after transplantation. During the year 2003-04, the company launched ENBREL which is a breakthrough treatment for Rheumatoid Arthritis. They also launched RAPAMUNE, an immunosuppressant for prevention of rejection after renal transplantation.
During the year 2004-05, the company sold their bulk drug manufacturing facility at Ghatkopar, Mumbai, as a going concern on slump sale basis to Ariane Orgachem Pvt Ltd. The company dissolved Credence Investment and Finance Ltd on July 21, 2004. Also, they dissolved Magnet Pharma and Allied Products Ltd and Keystone Pharma Ltd, wholly owned subsidiaries of the company during the year. In April 2006, the company assigned the Forhans trade marks to John Oak Remedies Pvt Ltd, and the know-how for manufacture of toothpaste, toothpowder and toothbrushes was licensed to them on a non-exclusive basis for a consideration of Rs 2.25 crore on transaction.
During the year 2006-07, the Consumer Health Care division launched the 60 gm tube pack of their product, Anne French .This division is working towards strengthening the consumer franchise for the Analgesics and Hair Remover products. During the year 2007-08, the company launched TYGACIL, a hospital injectable antibiotic for life threatening infections such as complicated intra-abdominal infections and complicated skin and skin structure infections. In January 2009, Wyeth, USA has entered into a definitive Merger Agreement with Pfizer, USA under which Pfizer, USA will acquire Wyeth, USA in a cash-and-stock transaction.
Under one plan with Unbelievable lowest price
( Equity cash, Nse fno, jackpot call, sure shot call, btst/stbt call/nifty tips/bank nifty tips)
for free trial visit Nse Share tips
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
